<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css">

Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.

dc.contributor.author

Wu, Li-Tzy

dc.contributor.author

John, William S

dc.contributor.author

Mannelli, Paolo

dc.contributor.author

Morse, Eric D

dc.contributor.author

Anderson, Alyssa

dc.contributor.author

Schwartz, Robert P

dc.date.accessioned

2023-09-01T17:02:13Z

dc.date.available

2023-09-01T17:02:13Z

dc.date.issued

2023-08

dc.date.updated

2023-09-01T17:02:12Z

dc.description.abstract

Background

Pharmacy administration and dispensing of methadone treatment for opioid use disorder (PADMOUD) may address inadequate capability of opioid treatment programs (OTPs) in the US by expanding access to methadone at community pharmacies nationally. PADMOUD is vastly underutilized in the US. There is no published US study on OUD patients' perspectives on PADMOUD. Data are timely and needed to inform the implementation of PADMOUD in the US to address its serious opioid overdose crisis.

Methods

Patient participants of the first completed US trial on PADMOUD through electronic prescribing for methadone (parent study) were interviewed to explore implementation-related factors for PADMOUD. All 20 participants of the parent study were invited to participate in this interview study. Each interview was recorded and transcribed verbatim. Thematic analysis was conducted to identify emergent themes.

Results

Seventeen participants completed the interview. Patients' perspectives on PADMOUD were grouped into five areas. Participants reported feasibility of taking the tablet formulation of methadone at the pharmacy and identified benefits from PADMOUD (e.g., better access, efficiency, convenience) compared with usual care at the OTP. Participants perceived support for PADMOUD from their family/friends, OTP staff, and pharmacy staff. PADMOUD was perceived to be a great option for stable patients with take-home doses and those with transportation barriers. The distance (convenience), office hours, and the cost were considered factors most influencing their decision to receive methadone from a pharmacy. Nonjudgmental communication, pharmacists' training on methadone treatment, selection of patients (stable status), workflow of PADMOUD, and protection of privacy were considered key factors for improving operations of PADMOUD.

Conclusion

This study presents the first findings on patient perspectives on PADMOUD. Participants considered pharmacies more accessible than OTPs, which could encourage more people to receive methadone treatment earlier and help transition stable patients from an OTP into a local pharmacy. The findings have timely implications for informing implementation strategies of PADMOUD that consider patients' views and needs.
dc.identifier

10.1186/s13722-023-00399-6

dc.identifier.issn

1940-0632

dc.identifier.issn

1940-0640

dc.identifier.uri

https://hdl.handle.net/10161/28945

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Addiction science & clinical practice

dc.relation.isversionof

10.1186/s13722-023-00399-6

dc.subject

Humans

dc.subject

Opioid-Related Disorders

dc.subject

Methadone

dc.subject

Analgesics, Opioid

dc.subject

Qualitative Research

dc.subject

Pharmacies

dc.subject

Opiate Substitution Treatment

dc.title

Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.

dc.type

Journal article

duke.contributor.orcid

Wu, Li-Tzy|0000-0002-5909-2259

duke.contributor.orcid

Mannelli, Paolo|0000-0002-7834-6138

pubs.begin-page

45

pubs.issue

1

pubs.organisational-group

Duke

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

Psychiatry, Child & Family Mental Health & Community Psychiatry

pubs.organisational-group

Center for Child and Family Policy

pubs.organisational-group

Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology

pubs.publication-status

Published

pubs.volume

18

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Wu 2023 Patient perspectives on community pharmacy administerd_dispensing of methadone Tx_qualitative.pdf
Size:
865.35 KB
Format:
Adobe Portable Document Format
Description:
Published version